Biotechnology in Asia-Pacific

Biotechnology in Asia-Pacific


  • Products Id :- OHMF4629
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in Asia-Pacific

Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Asia-Pacific biotechnology industry had total revenues of USD 92.8bn in 2017, representing a compound annual growth rate (CAGR) of 6% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 49.5bn, equivalent to 53.4% of the industry's overall value.

- The Asia-Pacific market is driven mainly by China and Japan, who together made up 58.6% of the industry in 2017.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific biotechnology market by value in 2017?

- What will be the size of the Asia-Pacific biotechnology market in 2022?

- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Asia-Pacific's biotechnology market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Category segmentation 9

Geography segmentation 10

Market Outlook 11

Market value forecast 11

Five Forces Analysis 12

Summary 12

Buyer power 13

Supplier power 14

New entrants 15

Threat of substitutes 17

Degree of rivalry 18

Leading Companies 19

Astellas Pharma Inc. 19

Merck & Co., Inc. 22

Mitsubishi Tanabe Pharma Corporation 25

Takeda Pharmaceutical Company Limited 28

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33

List of Figures

Figure 1: Asia-Pacific biotechnology industry value: USD billion, 2013-17

Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Asia-Pacific biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2017

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

List of Tables

Table 1: Asia-Pacific biotechnology industry value: USD billion, 2013-17

Table 2: Asia-Pacific biotechnology industry category segmentation: USD billion, 2017

Table 3: Asia-Pacific biotechnology industry geography segmentation: USD billion, 2017

Table 4: Asia-Pacific biotechnology industry value forecast: USD billion, 2017-22

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials (USD )

Table 7: Astellas Pharma Inc.: key financials (JPY)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: Mitsubishi Tanabe Pharma Corporation: key facts

Table 13: Mitsubishi Tanabe Pharma Corporation: key financials (USD )

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (JPY)

Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 16: Takeda Pharmaceutical Company Limited: key facts

Table 17: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 18: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 19: Takeda Pharmaceutical Company Limited: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24500
Site License
USD 700 INR 49000
Corporate User License
USD 1050 INR 73500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com